{"id":"W4410809345","doi":"10.1200/jco.2025.43.16_suppl.6545","title":"A phase 2 study of olutasidenib in relapsed/refractory acute myeloid leukemia: Outcomes by number of prior treatment regimens.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Refractory (planetary science); Myeloid leukemia; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002555723,0.001292721,0.00155879,0.0005711268,0.0003341999,0.000780198,0.0006590538,0.0007240481,0.003168647],"category_scores_gemma":[0.001100804,0.0004990501,0.00153053,0.0004701795,0.0006876083,0.0007217746,0.0005095099,0.002187194,0.0006909272],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007365244,"about_ca_system_score_gemma":0.001248424,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008320212,"about_ca_topic_score_gemma":0.001656811,"domain_scores_codex":[0.9992582,0.0004074564,0.00002931144,0.000102978,0.0000860997,0.0001158711],"domain_scores_gemma":[0.99906,0.0001275093,0.0002582716,0.00009274912,0.00005228689,0.0004091335],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8046615,0.07995506,0.03197738,0.0004609617,0.001899983,0.0002093997,0.0002230556,0.001633118,0.02028567,0.0002107364,0.003229094,0.05525414],"study_design_scores_gemma":[0.4702755,0.4423324,0.07588292,0.00004202235,0.001210071,0.0004598577,0.00009789105,0.002023694,0.003566581,0.0002742091,0.003786635,0.00004828558],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943219,0.001066508,0.000295094,0.0001741857,0.00004173182,0.001928214,0.001291723,0.00003379785,0.0008468541],"genre_scores_gemma":[0.9889961,0.001010405,0.001270815,0.0006336716,0.0001706664,0.002103267,0.004089349,0.00002329871,0.00170237],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003168647,"threshold_uncertainty_score":0.01351613,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06511744294923902,"score_gpt":0.4777576493588462,"score_spread":0.4126402064096072,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}